Alkaptonuria (AKU)

Alkaptonuria (AKU) is a rare, inherited metabolic disease. It happens when the body cannot break down a chemical called homogentisic acid (HGA). This problem comes from a missing or very weak enzyme called homogentisate 1,2-dioxygenase (HGD). Because the enzyme is missing or weak, HGA builds up in the body over many years. Extra HGA leaves the body in urine and turns the urine dark brown or almost black when the urine stands in air. Over time, extra HGA also deposits inside tissues like cartilage, tendons, and heart valves. The deposits slowly change color and become a dark pigment. Doctors call this tissue darkening ochronosis. Ochronosis makes joints stiff and painful, damages the spine and large joints, and can cause kidney and prostate stones. The disease is autosomal recessive, which means a child gets one faulty copy of the HGD gene from each parent.

---

What happens in AKU (plain explanation)

Your body breaks down the amino acids phenylalanine and tyrosine every day. These amino acids come from protein in food and from normal body turnover. During this breakdown, your body makes a middle chemical called homogentisic acid (HGA). In a healthy person, the HGA enzyme (HGD) changes HGA into the next safe step. In AKU, the HGD enzyme is not working well or is missing. So HGA cannot move forward. HGA builds up in blood and tissues. Some HGA leaves in urine and turns dark when it meets air. Some HGA turns into a sticky, dark pigment that settles in cartilage, tendons, intervertebral discs, and heart valves. The pigment is what doctors call ochronosis. Ochronosis makes tissues stiff, brittle, and less elastic. This is why joints and the spine hurt and wear out early in life. This is also why the outer ear, the white of the eye, and sometimes skin folds look bluish-black or slate colored in adults with long-standing disease.

---

Who gets AKU

AKU affects both males and females. A person must inherit two faulty copies of the HGD gene, one from each parent. Parents with only one faulty copy are called carriers. Carriers are usually healthy and have no symptoms. When two carriers have a child, there is a 25% chance that the child will have AKU, a 50% chance the child will be a carrier, and a 25% chance the child will have two normal copies. AKU occurs around the world but is more common in some regions and families due to higher carrier rates. Symptoms often start with dark urine in infancy, but joint and spine problems usually show up later, often in the 20s to 40s, and slowly get worse.

---

Types of AKU

There is one basic genetic disease—hereditary alkaptonuria due to HGD deficiency. But doctors and researchers may describe “types” or patterns in a few practical ways. These are not strict official types like in some other diseases. They are useful ways to talk about how the disease shows up in life.

1. Primary (hereditary) AKU
   This is the classic inherited condition caused by changes (variants) in the HGD gene. It is autosomal recessive. This is what people usually mean by alkaptonuria.

2. Endogenous ochronosis due to AKU
   This means tissue darkening (ochronosis) that comes from inside the body because of the HGA build-up in AKU. It is a feature of long-standing AKU.

3. Phenotype patterns (how the disease shows up most strongly)

   • Musculoskeletal-dominant pattern: spine, hip, knee, and shoulder pain and stiffness are the main problems.

   • Cardio-renal-urologic pattern: heart valve thickening or narrowing, kidney stones, or prostate stones are more prominent.

   • Mixed pattern: joint problems plus kidney/urinary or heart findings occur together.

   • Biochemical AKU with few symptoms (early stage): urine darkens, but pain and stiffness are still mild or not yet present.

4. Severity stages (practical, life-course view)

   • Early biochemical phase: dark urine from infancy or childhood; few other signs.

   • Ochronosis phase: slate-blue or black discoloration of ear cartilage and whites of the eyes appears in adulthood.

   • Degenerative phase: progressive spinal stiffness and large-joint arthritis, with possible stones and heart valve disease.

5. Ochronosis not due to AKU (important look-alike)
   This is called exogenous ochronosis. It comes from outside chemicals (for example, long-term skin exposure to certain products). It is not the same as AKU, but it can look similar on the skin. Doctors separate it from hereditary AKU by history, lab tests, and genetics.

---

Causes

AKU has one root cause: changes in the HGD gene that make the HGD enzyme very weak or absent. The items below explain this core cause in simple ways, and include factors that increase the chance of AKU or change how strongly it shows up. Think of this as “causes and contributors.”

1. Autosomal recessive inheritance: a child gets two faulty HGD copies, one from each carrier parent.

2. Missense variants in HGD: a single “letter” change makes a faulty enzyme that cannot do its job well.

3. Nonsense variants: a change creates a “stop” signal too early, so the enzyme is short and nonfunctional.

4. Frameshift variants: small insertions or deletions shift the code and ruin the enzyme build.

5. Splice-site variants: the gene message is cut and joined wrongly, so the finished enzyme is abnormal.

6. Large deletions or duplications in HGD: big pieces of the gene are missing or repeated, stopping normal enzyme production.

7. Compound heterozygosity: the child gets two different faulty HGD variants, one from each parent, leading to disease.

8. Homozygosity: the child gets the same faulty HGD variant from both parents, often seen in close-related marriages.

9. Consanguinity (parents are related): increases the chance that both parents carry the same rare HGD variant.

10. Founder effects in some communities: a rare HGD variant is more common in a group due to historical inheritance patterns.

11. Reduced enzyme stability: some variants make an enzyme that breaks down quickly and cannot keep up with HGA.

12. Active-site disruption: some variants change the part of HGD that grabs HGA, so the enzyme cannot process it.

13. Low enzyme expression: promoter or regulatory changes reduce how much HGD enzyme the body makes.

14. Combination with a new (de novo) variant: rarely, one new variant appears in the child plus a carrier variant from one parent.

15. Kidney function changes: poor kidney function can raise HGA levels, making tissue deposition worse.

16. High lifetime intake of protein rich in phenylalanine/tyrosine: does not cause AKU by itself, but can increase HGA load in someone who already has AKU.

17. Aging: pigment builds up slowly over decades, so signs and joint damage increase with age.

18. High mechanical joint stress: heavy labor or repetitive impact may speed joint wear in people with AKU.

19. Oxidative processes in tissues: HGA is prone to oxidation and polymerization, which promotes dark pigment deposition.

20. Delayed recognition of AKU: if the disease is not recognized early, long-term HGA exposure continues and more damage builds up.

---

Common symptoms and signs

1. Dark urine that turns brown or black on standing
   Urine may look normal when fresh but darkens after minutes to hours in air. Parents may notice dark stains in diapers.

2. Bluish-black ear cartilage
   The outer ear (especially the rim) may look slate-blue or black in adults. The ear feels firm and thick.

3. Dark streaks on the whites of the eyes
   A brown or gray-blue tint appears at the edge of the cornea (near the place where the white meets the clear part).

4. Stiff lower back
   The low back becomes stiff and sore, often starting in early to mid-adulthood, and slowly gets worse.

5. Hip and knee pain
   Large joints wear out early. Pain and stiffness make walking, climbing stairs, or standing up harder.

6. Shoulder pain and limited reach
   The shoulder joint may ache and lose range. Reaching overhead or behind the back becomes difficult.

7. Reduced range of motion
   Joints feel tight. Bending, twisting, or turning the neck or lower back becomes limited.

8. Early, severe osteoarthritis
   Joint cartilage becomes brittle and breaks down earlier than normal. Bone spurs can form.

9. Tendon or ligament thickening
   The Achilles tendon and other tendons may feel thick and tender due to pigment and calcium buildup.

10. Kidney stones
    People can have flank pain, blood in urine, or urinary infections due to stones.

11. Prostate stones in men
    These can cause urinary difficulty, pain, or infections.

12. Heart valve problems (often aortic valve)
    Over many years, the aortic valve can stiffen and narrow. This may cause chest pain, breathlessness, or a heart murmur.

13. Skin darkening in folds or where sweat collects
    The armpits, groin, or other areas may show a brownish tint in long-standing disease.

14. Cracking sounds and joint swelling
    Joints may crack or pop. They can swell after activity due to irritation.

15. Fatigue from chronic pain and limited movement
    Ongoing pain and stiffness can reduce sleep and daily energy.

---

Diagnostic tests

Doctors diagnose AKU by combining your story, your exam, simple office clues, and specific lab and imaging tests. Below are 20 tests grouped by type. Each test has a simple description and why it helps.

A) Physical examination

1. General exam with joint and spine check
   The doctor looks at posture, gait, and how you move. They feel the spine and large joints for tenderness and stiffness.

2. Ear and eye inspection for ochronosis
   The doctor inspects the rim of the ear for slate-blue or black color and looks at the whites of the eyes for dark streaks.

3. Heart listening (cardiac auscultation)
   The doctor listens for a heart murmur that could suggest a stiff or narrowed aortic valve.

4. Skin exam in folds and sun-exposed areas
   The doctor looks for brown or gray-blue skin discoloration that fits long-standing AKU.

B) Manual/bedside functional tests

5. Spine flexibility test (e.g., Schober-type measure)
   The clinician measures how much your lower back lengthens when you bend forward. Reduced change suggests stiffness.

6. Hip and knee range-of-motion testing
   The clinician gently moves your joints in set patterns. Pain or limits suggest joint wear from ochronosis.

7. Gait and sit-to-stand assessment
   Simple timed tasks show how pain and stiffness affect daily function. Worsening times can track disease impact.

C) Laboratory and pathological tests

8. Urine homogentisic acid (HGA) quantification (gold-standard lab test)
   A specialized lab measures the exact amount of HGA in urine, usually by gas chromatography–mass spectrometry. Very high HGA confirms AKU.

9. Urine organic acid profile
   This broader test also shows high HGA and helps rule out other metabolic problems.

10. Simple “black urine” observation test
    Fresh urine is collected and left standing or alkalinized in the lab. Darkening toward brown or black supports AKU (a supportive clue, not the only test).

11. Ferric chloride or Benedict’s-type color tests (historical/supportive)
    These older chemical tests can show color changes with HGA. They are supportive but not definitive.

12. Plasma HGA level (if available)
    Some centers measure HGA in blood to support the diagnosis and track the biochemical burden.

13. Renal function tests (creatinine, eGFR)
    These show how well the kidneys can clear HGA and help plan care for stones or other issues.

14. Genetic testing for HGD variants
    DNA testing finds the exact changes in the HGD gene. It confirms the cause and allows family testing and counseling.

15. Tissue pathology (cartilage or tendon, when obtained for surgery)
    A pathologist can see dark ochronotic pigment in cartilage under the microscope. This is confirmatory in the right clinical setting.

D) Electrodiagnostic and electrical monitoring

16. Electrocardiogram (ECG)
    This quick, noninvasive test records heart rhythms. It can show strain or rhythm issues in people who have heart valve disease from long-standing AKU.

17. Electromyography/nerve conduction studies (EMG/NCS) in selected cases
    These tests check nerves and muscles if there are symptoms suggesting nerve root irritation from spinal degeneration in AKU.

E) Imaging tests

18. X-rays of the spine and major joints
    X-rays can show early disc calcification, joint space narrowing, and bone spurs. These patterns fit ochronotic arthritis.

19. MRI of the spine or a painful joint
    MRI shows cartilage, discs, and soft tissues in detail. It helps map degeneration and plan treatment.

20. Ultrasound/CT for kidney and prostate stones; echocardiogram for heart valves
    Ultrasound or CT detects urinary stones. An echocardiogram is a heart ultrasound that shows thick or narrowed valves.

Non-pharmacological treatments

Each item includes what it is, purpose, and mechanism (how it helps).

1. Education and genetic counseling
   Purpose: Understand inheritance, testing, and family planning.
   Mechanism: Explains autosomal recessive risk (25% chance for each child if both parents are carriers) and options such as carrier testing and prenatal or preimplantation genetic testing.

2. Care coordination in a specialized AKU/rare-disease clinic
   Purpose: Build a team (metabolic specialist, cardiology, urology, orthopedics, physical and occupational therapy, dietetics).
   Mechanism: Regular, structured monitoring catches problems early (joint damage, stones, valve disease).

3. Low-tyrosine/low-phenylalanine dietary pattern (especially if taking nitisinone)
   Purpose: Prevent high blood tyrosine (a nitisinone side effect) and reduce substrate load.
   Mechanism: Moderates intake of high-protein foods so tyrosine/phenylalanine levels stay safer; dietitian tailors a plan to avoid malnutrition.

4. Protein moderation, not starvation
   Purpose: Balance protein needs for muscle/joint health while avoiding excess tyrosine/phenylalanine.
   Mechanism: Keeps diet adequate (enough calories and micronutrients) while controlling amino acid load.

5. Hydration routine
   Purpose: Lower stone risk and help flush HGA.
   Mechanism: Higher urine volume reduces crystal formation and pigment concentration.

6. Citrate-rich diet practices (citrus fruits, veggies; dietitian-guided)
   Purpose: Support urine citrate and pH balance alongside medical care.
   Mechanism: Citrate can bind calcium and reduce certain stone formation tendencies.

7. Weight management
   Purpose: Reduce load on spine, hips, and knees.
   Mechanism: Less mechanical stress slows arthritis progression and eases pain.

8. Low-impact aerobic exercise (walking, cycling, swimming)
   Purpose: Preserve mobility, heart health, and mood.
   Mechanism: Moves joints without pounding them, improves circulation, and supports weight control.

9. Targeted strengthening (core, hip abductors, quadriceps, glutes)
   Purpose: Stabilize spine and joints; reduce pain.
   Mechanism: Strong muscles offload damaged cartilage and discs.

10. Flexibility and posture therapy
    Purpose: Maintain range of motion and spinal alignment.
    Mechanism: Stretching and postural drills improve mechanics and reduce stiffness.

11. Physical therapy (PT) plan
    Purpose: Personalized exercises, manual techniques, pacing strategies.
    Mechanism: PT guides safe activity progressions and protects vulnerable joints.

12. Occupational therapy (OT) and activity pacing
    Purpose: Adapt daily tasks, use energy wisely, prevent flares.
    Mechanism: OT recommends tools (reachers, jar openers) and joint-saving techniques.

13. Bracing/orthotics and footwear optimization
    Purpose: Improve alignment and reduce pain during walking/standing.
    Mechanism: Custom insoles or braces redistribute load and improve stability.

14. Heat and cold therapy
    Purpose: Short-term pain control and stiffness relief.
    Mechanism: Heat relaxes muscles; cold calms inflamed tissues.

15. Cognitive-behavioral pain strategies and mindfulness
    Purpose: Reduce stress-pain cycle; improve coping.
    Mechanism: Skills training lowers central pain amplification and anxiety.

16. Smoking cessation
    Purpose: Improve circulation, bone health, and surgical outcomes.
    Mechanism: Better tissue oxygenation and healing; lower cardiovascular risk.

17. Alcohol moderation
    Purpose: Protect liver, sleep quality, and fall risk in painful joints.
    Mechanism: Reduces sedation, inflammation, and metabolic strain.

18. Eye protection and regular eye checks if on nitisinone
    Purpose: Catch tyrosine-related keratopathy early (may cause pain or light sensitivity).
    Mechanism: Routine slit-lamp exams; sunglasses and artificial tears as advised.

19. Stone-risk counseling
    Purpose: Recognize stone symptoms early and act quickly.
    Mechanism: Education on flank pain, blood in urine, urinary retention, and when to seek urgent care.

20. Cardiac monitoring schedule
    Purpose: Detect valve thickening/calcification before severe symptoms.
    Mechanism: Periodic echocardiograms guide timing of intervention.

---

Drug treatments

Important: Medication doses below are general educational ranges for adults. Individual plans vary by age, kidney/liver function, other conditions, and local guidelines. Always follow your specialist’s prescription and monitoring plan.

1. Nitisinone (HPPD inhibitor; disease-modifying)
   Dose: Common adult regimens use 10 mg once daily; some centers may individualize.
   When: Daily, long-term; requires monitoring.
   Purpose: Dramatically lowers HGA production to slow ochronosis.
   Mechanism: Blocks 4-hydroxyphenylpyruvate dioxygenase upstream of HGA, cutting HGA levels in urine and tissues.
   Side effects: Raised blood tyrosine (risk of corneal crystals/keratopathy, photophobia), potential skin/hair changes; needs low-tyrosine/phenylalanine diet and regular blood checks.

2. Acetaminophen (Paracetamol) (analgesic)
   Dose: 500–1,000 mg every 6–8 hours, max 3,000–4,000 mg/day (lower if liver disease or per doctor).
   When: For mild to moderate pain.
   Purpose: Safer baseline pain relief.
   Mechanism: Central pain-modulating effects without anti-platelet or strong GI risks.
   Side effects: Liver toxicity if overdosed or combined with alcohol.

3. NSAIDs (e.g., ibuprofen, naproxen)
   Dose: Ibuprofen 200–400 mg every 6–8 hours; Naproxen 250–500 mg twice daily.
   When: For inflammatory flares; use shortest effective course.
   Purpose: Reduce pain and inflammation.
   Mechanism: COX inhibition lowers prostaglandins.
   Side effects: Stomach ulcers/bleeding, kidney strain, fluid retention; avoid if high GI/renal risk; consider protection below.

4. COX-2 selective NSAID (e.g., celecoxib)
   Dose: 100–200 mg once or twice daily.
   When: If NSAID needed but GI risk is high.
   Purpose: Pain relief with less stomach risk than nonselective NSAIDs.
   Mechanism: Preferential COX-2 inhibition.
   Side effects: Still possible cardiovascular and renal risks.

5. Gastroprotection when on NSAIDs (e.g., omeprazole)
   Dose: 20 mg once daily (typical).
   When: Combine when GI risk is present and NSAIDs are necessary.
   Purpose: Prevent ulcers/bleeds.
   Mechanism: Proton pump inhibition reduces gastric acid.
   Side effects: Headache, diarrhea; long-term risks discussed with clinician.

6. Duloxetine (SNRI)
   Dose: 30–60 mg once daily.
   When: Chronic musculoskeletal pain or mixed nociceptive/neuropathic pain.
   Purpose: Lower pain intensity and improve function.
   Mechanism: Central serotonin/norepinephrine modulation.
   Side effects: Nausea, dry mouth, sleep changes; interactions apply.

7. Tramadol (weak opioid/SNRI-like)
   Dose: 25–50 mg every 6 hours as needed; use minimal dose and short duration.
   When: Breakthrough pain not controlled by other options.
   Purpose: Short-term rescue analgesia.
   Mechanism: Mu-opioid plus monoamine effects.
   Side effects: Drowsiness, constipation, dependency risk; avoid with certain antidepressants (serotonin syndrome risk).

8. Intra-articular corticosteroid (e.g., triamcinolone)
   Dose: Common knee dose 20–40 mg per joint; spacing typically ≥3 months.
   When: Painful joint flares with significant inflammation.
   Purpose: Potent, local anti-inflammatory relief.
   Mechanism: Dampens synovitis inside the joint.
   Side effects: Temporary flare, cartilage risks if overused, glucose rises.

9. Hyaluronic acid (viscosupplement) injections
   Dose: Regimens vary (single-shot or weekly for 3–5 weeks).
   When: Symptomatic knee OA where appropriate.
   Purpose: Lubrication and shock absorption.
   Mechanism: Boosts synovial fluid viscosity.
   Side effects: Local pain/swelling; benefit varies.

10. Stone-related medications (as indicated)
    Examples and doses:
    • Tamsulosin 0.4 mg nightly to aid passage of distal ureteral stones.
    • Potassium citrate 10–20 mEq two or three times daily to raise urine citrate/pH (per urology).
    Purpose: Help stone passage and reduce recurrence risk.
    Mechanism: Alpha-blockade relaxes ureter; citrate binds calcium and alkalinizes urine.
    Side effects: Dizziness (tamsulosin), GI upset (citrate); monitoring advised.

---

Dietary “molecular” supplements

Always discuss supplements with your clinician, especially if you take nitisinone or have kidney/heart conditions. Doses below are common educational ranges, not personal prescriptions.

1. Vitamin C (ascorbic acid)
   Dose: 250–500 mg/day (avoid very high chronic doses unless advised).
   Function: Antioxidant; historically explored in AKU.
   Mechanism: May reduce HGA oxidation to pigment; evidence for clinical endpoints is mixed.

2. Vitamin D3
   Dose: 1,000–2,000 IU/day (or per blood level).
   Function: Bone and muscle health.
   Mechanism: Maintains calcium balance and bone strength in arthritis/limited mobility.

3. Omega-3 fatty acids (fish oil or algae oil)
   Dose: 1–2 g/day EPA+DHA.
   Function: Anti-inflammatory support.
   Mechanism: Competes with arachidonic acid pathways to reduce inflammatory mediators.

4. N-acetylcysteine (NAC)
   Dose: 600 mg once or twice daily.
   Function: Antioxidant support via glutathione.
   Mechanism: Replenishes intracellular glutathione and may limit oxidative pigment formation.

5. Curcumin (turmeric extract, standardized)
   Dose: 500–1,000 mg/day with piperine or lipid-based forms.
   Function: Joint symptom relief in some patients.
   Mechanism: Down-regulates NF-κB and inflammatory cytokines.

6. Quercetin
   Dose: 250–500 mg/day.
   Function: Antioxidant/anti-inflammatory polyphenol.
   Mechanism: Free-radical scavenging and enzyme modulation.

7. Resveratrol
   Dose: 100–250 mg/day.
   Function: Antioxidant support.
   Mechanism: Influences sirtuins and oxidative stress pathways.

8. Coenzyme Q10
   Dose: 100–200 mg/day.
   Function: Mitochondrial antioxidant support, fatigue reduction.
   Mechanism: Electron transport and membrane stabilization.

9. Magnesium (e.g., magnesium citrate)
   Dose: 200–400 mg/day elemental magnesium.
   Function: Muscle relaxation; may aid bowel regularity if constipated on pain meds.
   Mechanism: Modulates neuromuscular excitability; citrate form may support urinary citrate.

10. Glucosamine with chondroitin
    Dose: 1,500 mg/day glucosamine ± 1,200 mg/day chondroitin.
    Function: Symptomatic joint support (variable response).
    Mechanism: Building-block substrates for cartilage matrix; anti-inflammatory effects in some.

Note: Supplements do not replace nitisinone or medical therapy. Quality varies—choose reputable brands.

---

Regenerative / stem-cell” drugs or approaches

Honest note: There are no approved immune-booster or stem-cell drugs that cure AKU. The items below summarize supportive or investigational directions so you can discuss them knowledgeably with your specialist.

1. Autologous platelet-rich plasma (PRP) injections
   Dose: Procedural (no standard “mg” dose).
   Function: Symptomatic joint pain relief in selected osteoarthritis cases.
   Mechanism: Concentrated platelets release growth factors that may modulate inflammation and healing; not disease-curing for AKU.

2. Autologous cartilage cell procedures (e.g., ACI/MACI)
   Dose: Surgical technique; not a drug.
   Function: Focal cartilage repair in carefully selected lesions.
   Mechanism: Implanting cultured chondrocytes to fill defects; not applicable to widespread ochronotic degeneration.

3. Hyaluronic acid (already listed above)
   Dose: Injection series per product.
   Function: Lubrication; symptom relief.
   Mechanism: Improves synovial viscosity; not regenerative in the true sense.

4. Mesenchymal stem cell (MSC) injections (experimental)
   Dose: Investigational; no approved dosing for AKU.
   Function: Research interest for osteoarthritis; not proven for AKU.
   Mechanism: Paracrine anti-inflammatory effects; evidence in AKU is lacking.

5. Gene therapy concepts targeting HGD (preclinical/experimental)
   Dose: Not available clinically.
   Function: Theoretically correct the enzyme defect.
   Mechanism: Deliver functional HGD gene to produce the missing enzyme; research only.

6. Teriparatide or denosumab for co-existing severe osteoporosis (context-specific)
   Dose: Teriparatide 20 mcg daily (max 2 years); Denosumab 60 mg SC every 6 months.
   Function: Bone strength when true osteoporosis is present—not AKU-specific.
   Mechanism: Anabolic (teriparatide) or antiresorptive (denosumab) effects; prescribed only when indicated.

---

Surgeries

1. Total joint replacement (hip or knee arthroplasty)
   Why: End-stage, painful arthritis that limits walking/sleep and fails conservative care.
   What happens: Damaged joint surfaces are removed and replaced with artificial components to restore alignment and motion.

2. Spine surgery (decompression ± fusion)
   Why: Severe spinal stenosis, nerve compression (sciatica, weakness), or instability that does not respond to therapy/meds.
   What happens: Surgeons remove bone/ligament that compress nerves and sometimes fuse segments to stabilize.

3. Shoulder arthroplasty or debridement
   Why: Disabling shoulder arthritis or rotator cuff/tendon issues aggravated by ochronosis.
   What happens: Replace joint or clean damaged tissue to reduce pain and improve function.

4. Cardiac valve surgery (repair or replacement, often aortic)
   Why: Advanced valve thickening/calcification with heart failure signs or severe regurgitation/stenosis.
   What happens: Diseased valve is repaired or replaced with mechanical or tissue valve to restore blood flow.

5. Stone procedures (ureteroscopy, laser lithotripsy, ESWL)
   Why: Painful, obstructing kidney/ureter stones or large prostate stones.
   What happens: Endoscopic tools or focused shock waves break and remove stones; stents may be placed temporarily.

---

Prevention strategies

1. Family and carrier testing with genetic counseling to understand risks before pregnancy.

2. Early specialist referral once dark urine is noticed—start monitoring before damage accelerates.

3. Dietary moderation of protein, and low-tyrosine/phenylalanine plan if on nitisinone, to keep tyrosine safe.

4. Hydration habit to lower stone risk.

5. Weight control to protect joints.

6. Regular PT-guided exercise to maintain strength and mobility.

7. Avoid tobacco and limit alcohol to improve bone/joint and heart health.

8. Protect joints at work/home with ergonomic tools and pacing.

9. Scheduled surveillance: eyes (if on nitisinone), heart valves (echo), kidneys/prostate (imaging/urinalysis), and spine/joints (clinical review ± imaging).

10. Vaccinations and infection control to protect general health, especially before/after surgeries.

---

When to see a doctor

See a doctor soon if you notice:

• Dark urine since childhood or new darkening of urine on standing.

• New or worsening back stiffness, hip/knee pain, or loss of motion.

• Eye discomfort, pain, or light sensitivity (especially if taking nitisinone).

• Blood in urine, flank pain, or difficulty passing urine (possible stones).

• Shortness of breath, chest discomfort on exertion, fainting, or new swelling in legs (possible valve disease).

• Sudden severe joint pain, locking, or suspected tendon tear.

Seek urgent/emergency care for:

• Fever with severe back/joint pain, inability to walk, sudden weakness or numbness, or uncontrolled pain.

• Severe chest pain, fainting, or acute shortness of breath.

• Complete urinary blockage, high fever with chills, or severe colicky flank pain.

---

What to eat and what to avoid

1. Aim for balanced plates: plenty of vegetables, fruits, whole grains, and healthy fats.

2. Moderate protein: prioritize measured portions of lean poultry, fish, eggs, and dairy; avoid oversized servings.

3. If on nitisinone, follow a dietitian-led low-tyrosine/low-phenylalanine plan; avoid high-protein “bulking” diets.

4. Hydrate throughout the day: water at each meal and between meals; more with heat/exercise (unless restricted medically).

5. Choose citrate-rich foods (citrus, certain fruits/veggies) to support urinary chemistry for stone prevention.

6. Prefer anti-inflammatory staples: olive oil, nuts (portion-controlled), berries, leafy greens, legumes (portion-controlled for protein), and omega-3-rich fish.

7. Limit ultra-processed foods, excess salt, and sugary drinks that worsen inflammation and blood pressure.

8. Limit high-oxalate foods if you have calcium-oxalate stones (spinach, beets, nuts, chocolate)—follow your urologist’s advice.

9. Keep calcium adequate from food unless your clinician advises otherwise (dietary calcium can actually reduce oxalate absorption).

10. Alcohol in moderation or none, and avoid smoking altogether.

---

Frequently asked questions (FAQs)

1) Is alkaptonuria curable?
Not yet. We can slow the disease and protect function. Nitisinone lowers HGA and is the most disease-specific option today, but it is not a complete cure and needs careful monitoring.

2) What causes the dark urine?
Excess homogentisic acid in urine oxidizes and darkens after standing or contact with alkaline solutions, turning brown or black.

3) Why do joints and the spine get stiff so early?
HGA-derived pigment binds to cartilage and discs, making them brittle and prone to wear and tear. This leads to early osteoarthritis and spinal degeneration.

4) How is AKU diagnosed?
Typical clues are dark urine and bluish-black ear/eye cartilage. Lab tests confirm very high urine HGA. Genetic testing can identify HGD mutations. Imaging shows disc calcification and arthritic changes; heart ultrasound checks valves.

5) What age do symptoms start?
Urine darkening appears in infancy, but joint and spine symptoms commonly worsen in adulthood (30s–50s), as pigment accumulates.

6) Is nitisinone safe?
It can be effective but needs experienced supervision. It raises blood tyrosine, which can affect the cornea. Diet changes and regular blood/eye checks manage this risk.

7) Do vitamins or antioxidants cure AKU?
No. Some supplements may help with general oxidative stress or joint symptoms, but they do not replace medical therapy.

8) Can I exercise?
Yes—low-impact exercise is encouraged. It protects joints by strengthening muscles and helps weight control. A PT can tailor a safe plan.

9) Why do some people get heart valve problems?
Ochronotic pigment can stiffen aortic and mitral valves, causing leaks or narrowing over time. Regular echocardiograms detect this early.

10) Are kidney and prostate stones common?
They can occur due to pigment and crystal changes in urine. Hydration, citrate support, and urology care reduce risk and treat stones.

11) What about pregnancy and AKU?
AKU is genetic but does not usually worsen pregnancy. Parents may consider genetic counseling for family planning.

12) Will I need surgery?
Some people eventually need joint replacement, spine decompression, or valve or stone procedures. The goal is to delay surgery with good preventive care, but have it at the right time when needed.

13) Can children be tested?
Yes—urine HGA and genetic testing confirm AKU. Early diagnosis guides monitoring and education for lifelong care.

14) Do I need a special doctor?
Ideally, yes: a metabolic specialist familiar with AKU, working with orthopedics, cardiology, urology, PT/OT, dietetics, and ophthalmology.

15) Where should I start today?
Get a confirmatory diagnosis if unsure, ask about nitisinone and diet supervision, begin a PT-guided exercise plan, schedule heart/eye/stone monitoring, and build habits of hydration and joint protection.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 16, 2025.